Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 28, 2024BiologyOpen Access

Epigenetic Alterations in Alzheimer’s Disease: Impact on Insulin Signaling and Advanced Drug Delivery Systems

View Full Paper
Ask AI
Bookmark
Share

Authors

AGAlosh GreenyANAyushi NairPSPrashant Sadanandan

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Greeny et al. (2024) studied this question.

synapsesocial.com/papers/68e77330b6db6435876e7e1ahttps://doi.org/10.3390/biology13030157
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Insulin signaling and neuropathological changes in Alzheimer’s disease2025
  2. 2Targeting epigenetic mechanisms in amyloid-β–mediated Alzheimer’s pathophysiology: unveiling therapeutic potential2024 · 1 citations
  3. 3Insulin resistance as a driver of neuroinflammation and oxidative stress in Alzheimer's disease: Mechanistic links and therapeutic approaches2026
  4. 4Epigenetic modulations and nutrient interactions in Alzheimer's disease: unveiling potential therapeutic pathways2025
  5. 5Peripheral Insulin Resistance and Alzheimer's Disease: Possible Mediators Including Extracellular Vesicles2026 · 1 citations